Neurodegenerative Disorder-Targeting Compound 1 |
カタログ番号GC31311 |
神経変性障害を標的とする化合物1は、カルパイン阻害剤である(特許WO2010128102A1から抜粋、化合物63)。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1254699-12-1
Sample solution is provided at 25 µL, 10mM.
Neurodegenerative Disorder-Targeting Compound 1 is a carboxamide compound, used in the research of neurodegenerative disorders.
Neurodegenerative Disorder-Targeting Compound 1 can be used in the research of neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's disease[1].
[1]. MACK, Helmut., et al. CARBOXAMIDE COMPOUNDS AND THEIR USE AS CALPAIN INHIBITORS. WO 2010128102 A1.
Average Rating: 5
(Based on Reviews and 16 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *